Entheon Biomedical Corp.: Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments
Entheon Biomedical Corp.: Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments "Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, provides an update on license amendments issued to its clinical research organization, The Centre for Human Drug Research (CHDR). Entheon confirms that the CHDR, the Company's Netherlands-based partner clinical research organization, has received an amendment to its opioid license, enabling it to possess and conduct research with DMT. The opioid license amendment ...